Cytek Biosciences, Inc. (CTKB) vs OrthoPediatrics Corp. (KIDS)
Cytek Biosciences, Inc. and OrthoPediatrics Corp. are both Medical Devices companies. Cytek Biosciences, Inc. is the larger, with a market value of $744.8M against $591.1M — 1.3× the size. OrthoPediatrics Corp. grew revenue faster over the last twelve months: 14.5% against 5.44%. OrthoPediatrics Corp. has the higher net margin (−15.7% vs −39.0%) and the higher return on invested capital (−4.77% vs −46.4%). Across the 18 metrics below, OrthoPediatrics Corp. leads on 16 and Cytek Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | CTKB | KIDS | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 73.65% | 56.01% |
| Operating margin | (21.60%) | (11.87%) | (15.03%) |
| Net margin | (38.98%) | (15.72%) | (20.40%) |
| Free cash flow margin | (5.79%) | (0.73%) | (7.24%) |
| Return on equity | (23.04%) | (11.36%) | (15.32%) |
| Return on assets | (17.14%) | (7.83%) | (19.72%) |
| Return on invested capital | (46.36%) | (4.77%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack